These include immune system attacks on pancreatic β-cells (characteristic of type 1 diabetes), insulin resistance (when the body’s cells respond poorly to insulin, reducing glucose uptake), and β-cell dysfunction (impaired ability of β-cells to produce or release sufficient insulin, characteristic of type 2 diabetes), as well as genetic mutations [9,10]. This evidence concerns the gene INS and Insulin resistance.